Abeona Therapeutics Director Silverstein Sells 18,160 Shares for Tax Obligations

Christine Berni Silverstein, a director of Abeona Therapeutics Inc., sold 18,160 shares of common stock on June 15, 2026, at a weighted average price of $5.7101 per share. The sale was conducted to cover tax obligations associated with the vesting of restricted stock awards. The shares were sold in multiple transactions at prices ranging from $5.68 to $5.73. Following the transaction, Silverstein retains ownership of 119,562 shares. The filing includes standard footnotes explaining the tax-related nature of the sale and providing details about the price range. This Form 4 filing represents a routine insider transaction related to tax obligations rather than a discretionary sale of holdings.